Nurse Visitation for Chronic Disease
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, if you have chronic illnesses like hypertensive disorders that require treatment, you may not be eligible to participate.
What data supports the effectiveness of the treatment Transportation and Developmental Screening, Transportation, Screening, and Nurse-Visitation during Pregnancy and Infancy?
Research shows that nurse-supervised neonatal transport teams provide care comparable to physician-supervised teams, with significant improvements in the condition of infants during transport. This suggests that nurse involvement in transportation and care can be effective in managing health conditions.12345
Is nurse visitation for chronic disease safe for humans?
How does nurse visitation for chronic disease differ from other treatments?
Nurse visitation for chronic disease is unique because it involves personalized home visits by nurses, focusing on education and self-care, which can improve health outcomes and reduce healthcare costs. This approach is different from traditional treatments that may not offer the same level of individualized support and direct interaction in the patient's home environment.79111213
What is the purpose of this trial?
This study is a longitudinal cohort study that follows participants in a randomized clinical trial of a program of prenatal and early child home visiting on maternal and offspring risks for chronic disease.
Eligibility Criteria
This trial is for first-time pregnant women under 29 weeks with no severe chronic illnesses. It's aimed at those who have participated in a nurse home visiting program and face socioeconomic challenges, such as being unmarried, having less than a high school education, or being unemployed.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Prenatal and Early Childhood Home-Visiting
Intensive nurse home-visitation services during pregnancy and through the child's second birthday, including developmental screening and referral services for the child at the 6th, 12th, and 24th months of the child's life.
Long-term Follow-up
Participants are monitored for chronic disease and mortality outcomes approximately 30 years after delivery.
Treatment Details
Interventions
- Transportation and Developmental Screening
- Transportation, Screening, and Nurse-Visitation during Pregnancy and Infancy
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Colorado, Denver
Lead Sponsor
Medpace, Inc.
Industry Sponsor
Dr. August J. Troendle
Medpace, Inc.
Chief Executive Officer since 1992
MD from the University of Maryland, School of Medicine; MBA from Boston University
Dr. Reinilde Heyrman
Medpace, Inc.
Chief Medical Officer since 2017
MD
University of Rochester
Collaborator